Please provide your email address to receive an email when new articles are posted on . Researchers have discovered a link between neurotoxicity related to chimeric antigen receptor T-cell therapy and ...
Bottom Line: Incidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in patients who had hypophosphatemia (low blood phosphate levels).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback